Cambuí (Myrciaria floribunda (West ex Willd.) O. Berg): A potential nutritional supplement for inhibition of COVID-19 infections / Cambuí (Myrciaria floribunda (West ex Willd.) O. Berg): Um potencial suplemento nutricional para a inibição de infecções por COVID-19

• Autor(a) principal: Santos, Klebson Silva
• Data de Publicação: 2022
• Outros Autores: Nascimento, Ana Letícia Sirqueira, Barbosa, Andriele Mendonça, de Jesus, Anderson Alles, de Brito, Edy Sousa, Ribeiro, Paulo Riceli Vasconcelos, Ledo, Ana da Silva, da Silva, Ana Veruska Cruz
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Revista Veras
• Texto Completo: https://ojs.brazilianjournals.com.br/ojs/index.php/BRJD/article/view/44150
• topic: COVID-19; Myrciaria floribunda (West ex Willd.) O. Berg; Myrtaceae; Phenolic compounds; Pressurized hot water extraction.

In the present study, we suggest that the Myrciaria floribunda (West ex Willd.) O. Berg fruit (cambuí) is a natural source of potential molecules against COVID-19. Extracts from orange and purple cambuí were obtained by using pressurized hot water extraction (PHWE). Extraction overall yield was 39.66 ± 1.62% and 33.00 ± 8.44% for the extracts of purple and orange cambuí, respectively. All analyzed extracts showed high total phenolic contents, especially those of purple fruits (3870.37 ± 353.09 mg GAE/100g). The total flavonoid content was 693.16 ± 180.09 and 770.08 ± 103.62 mg RE/100g for purple and orange fruit extracts, respectively. The secondary metabolite profile exhibited ellagic acid, ellagitannins, and derivatives of caffeic acid and ellagic acid. PHWE showed a good alternative for molecules separation from cambuí with promising potential for further in vitro and in vivo evaluation against Covid-19 infections.